Physician

Alireza Zarineh, MD

According to 2025 Medicare claims, Alireza Zarineh, MD (NPI: 1790079218) practices pathology in the Newark, NJ market, with the plurality of this provider's patient population coming from Morris, NJ. This provider's primary affiliated billing organization is VANGUARD MEDICAL GROUP, PA (NPI: 1073674412; TIN: 222592636) and primary practice location at 07834-2908. Zarineh is affiliated with the Richmond Quality, LLC (ACO ID: A2704), Aledade 25 NJ MSSP Enhanced (ACO ID: A3891), Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171), and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under both the MSSP and REACH models.

Zarineh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 321 traditional Medicare patients, billed 1,500 HCPCS/CPT codes, and received $42,667 in Medicare payments. The top billing code was 88189 (Flow cytometry technique for dna or cell analysis, 16 or more markers). Part D data shows 18 prescription claims totaling $144 in drug costs. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $28,466 to $42,667. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $368 and ending at $144. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$67K$135K2015 Medicare payment: $28,466 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $54,884 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $119,256 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $133,038 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $134,809 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $96,314 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $56,554 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $54,802 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $60,240 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $42,667 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153051,107$28,466
20165591,792$54,884
20171,0073,611$119,256
20181,0184,270$133,038
20199484,130$134,809
20207492,868$96,314
20214531,772$56,554
20224571,890$54,802
20234332,025$60,240
20243211,500$42,667

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$262$5232020 Drug cost: $368 (USD; Tot_Drug_Cst)2021 Drug cost: $178 (USD; Tot_Drug_Cst)2022 Drug cost: $418 (USD; Tot_Drug_Cst)2023 Drug cost: $523 (USD; Tot_Drug_Cst)2024 Drug cost: $144 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R22$368
2021N/R17$178
2022N/R26$418
2023N/R36$523
2024N/R18$144

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
88189Flow cytometry technique for dna or cell analysis, 16 or more markers3940$70
88305Pathology examination of tissue using a microscope, intermediate complexity223670$30
88342Special stained specimen slides to examine tissue, initial procedure95202$29
88312Special stained specimen slides to identify organisms including interpretation and report48115$22
88313Special stained specimen slides to examine tissue including interpretation and report53144$10

Top 5 Part D drugs in 2024

By total drug costs.

Part D summary data is connected for 2024, but public drug-level costs are not available, so a Top 5 by total drug costs cannot be shown.

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Alireza Zarineh, MD?

Tedicare shows public-source Medicare data for Alireza Zarineh, MD (NPI 1790079218), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alireza Zarineh, MD have ACO affiliation data?

Alireza Zarineh, MD is shown with ACO affiliation data for Richmond Quality, LLC (MSSP, ACO ID A2704), Aledade 25 NJ MSSP Enhanced (MSSP, ACO ID A3891), Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171), and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Alireza Zarineh, MD?

Alireza Zarineh, MD is linked to VANGUARD MEDICAL GROUP, PA (billing NPI 1073674412) in the available physician profile data.

Does Alireza Zarineh, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.